⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATOS News
Atossa Therapeutics, Inc. Common Stock
Avenga Appoints Clay Van Doren as Chief Executive Officer
globenewswire.com
ATOS
Quantum Computing in Financial Services Market Set to Reach USD 6.3 Billion by 2032 as Banks Move from Experimentation to Quantum Advantage | DataM Intelligence
prnewswire.com
IBM
INTC
IONQ
GOOG
AMZN
HON
GE
HPQ
CSCO
ATOS
Atos Group has signed a binding agreement to sell Ideal GRP, one of its Nordic businesses, to MAIT Group
globenewswire.com
ATOS
Sword Group selected as part of the ATOS-led consortium for the European Commission’s DG DIGIT FREIA – Lot 1 Framework contract
globenewswire.com
ATOS
Atos Strengthens Leadership in Data & AI in Spain as the Country Moves Towards AI at Scale
globenewswire.com
ATOS
Atossa Therapeutics Wins 2025 Clinical Trials Arena Research and Development Excellence Award in Precision Endocrine Therapy Category
prnewswire.com
ATOS
Atossa Therapeutics Presents Four Clinical Trial Updates Highlighting (Z)-Endoxifen Research at the 2025 San Antonio Breast Cancer Symposium
prnewswire.com
ATOS
Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen
prnewswire.com
ATOS
Life Sciences BPO Market is expected to generate a revenue of USD 481.8 Billion by 2032, Globally, at 7.50% CAGR: Verified Market Research®
prnewswire.com
CTSH
ACN
IQV
INFY
RIVN
ATOS
Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum
prnewswire.com
ATOS